Annual Net Income
-$7.28 M
-$1.94 M-36.38%
30 April 2024
Summary:
Champions Oncology annual net profit is currently -$7.28 million, with the most recent change of -$1.94 million (-36.38%) on 30 April 2024. During the last 3 years, it has fallen by -$7.64 million (-2109.94%). CSBR annual net income is now -1427.74% below its all-time high of $548.00 thousand, reached on 30 April 2022.CSBR Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$1.31 M
+$1.42 M+1304.59%
31 July 2024
Summary:
Champions Oncology quarterly net profit is currently $1.31 million, with the most recent change of +$1.42 million (+1304.59%) on 31 July 2024. Over the past year, it has increased by +$3.38 million (+163.40%). CSBR quarterly net income is now at all-time high.CSBR Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$3.40 M
+$3.88 M+53.31%
31 July 2024
Summary:
Champions Oncology TTM net profit is currently -$3.40 million, with the most recent change of +$3.88 million (+53.31%) on 31 July 2024. Over the past year, it has increased by +$6.24 million (+64.75%). CSBR TTM net income is now -719.89% below its all-time high of $548.00 thousand, reached on 30 April 2022.CSBR TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSBR Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.4% | +163.4% | +64.8% |
| 3 y3 years | -2109.9% | +374.0% | -968.8% |
| 5 y5 years | -5784.4% | +327.7% | -255.3% |
CSBR Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1427.7% | at low | at high | +151.2% | -719.9% | +65.1% |
| 5 y | 5 years | -1427.7% | at low | at high | +151.2% | -719.9% | +65.1% |
| alltime | all time | -1427.7% | +44.6% | at high | +135.7% | -719.9% | +74.1% |
Champions Oncology Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | - | $1.31 M(-1304.6%) | -$3.40 M(-53.3%) |
| Apr 2024 | -$7.28 M(+36.4%) | -$109.00 K(-95.7%) | -$7.28 M(-25.2%) |
| Jan 2024 | - | -$2.53 M(+22.2%) | -$9.73 M(+0.9%) |
| Oct 2023 | - | -$2.07 M(-19.3%) | -$9.64 M(+27.1%) |
| July 2023 | - | -$2.57 M(+0.2%) | -$7.58 M(+42.1%) |
| Apr 2023 | -$5.33 M(-1073.5%) | -$2.56 M(+5.0%) | -$5.33 M(+71.1%) |
| Jan 2023 | - | -$2.44 M(>+9900.0%) | -$3.12 M(-2987.0%) |
| Oct 2022 | - | -$16.00 K(-95.0%) | $108.00 K(-73.1%) |
| July 2022 | - | -$319.00 K(-7.3%) | $401.00 K(-26.8%) |
| Apr 2022 | $548.00 K(+51.4%) | -$344.00 K(-143.7%) | $548.00 K(+150.2%) |
| Jan 2022 | - | $787.00 K(+184.1%) | $219.00 K(-44.0%) |
| Oct 2021 | - | $277.00 K(-261.0%) | $391.00 K(+240.0%) |
| July 2021 | - | -$172.00 K(-74.4%) | $115.00 K(-68.2%) |
| Apr 2021 | $362.00 K(-117.3%) | -$673.00 K(-170.2%) | $362.00 K(-132.0%) |
| Jan 2021 | - | $959.00 K(>+9900.0%) | -$1.13 M(-32.8%) |
| Oct 2020 | - | $1000.00(-98.7%) | -$1.68 M(+22.2%) |
| July 2020 | - | $75.00 K(-103.5%) | -$1.38 M(-34.2%) |
| Apr 2020 | -$2.09 M(-1735.2%) | -$2.17 M(-631.9%) | -$2.09 M(+1062.2%) |
| Jan 2020 | - | $407.00 K(+32.6%) | -$180.00 K(-81.2%) |
| Oct 2019 | - | $307.00 K(-147.9%) | -$956.00 K(-4.0%) |
| July 2019 | - | -$641.00 K(+153.4%) | -$996.00 K(-884.3%) |
| Apr 2019 | $128.00 K(-108.7%) | -$253.00 K(-31.4%) | $127.00 K(-150.4%) |
| Jan 2019 | - | -$369.00 K(-238.2%) | -$252.00 K(-714.6%) |
| Oct 2018 | - | $267.00 K(-44.6%) | $41.00 K(-112.8%) |
| July 2018 | - | $482.00 K(-176.3%) | -$320.00 K(-78.3%) |
| Apr 2018 | -$1.48 M(-78.6%) | -$632.00 K(+731.6%) | -$1.48 M(-54.8%) |
| Jan 2018 | - | -$76.00 K(-19.1%) | -$3.27 M(-29.0%) |
| Oct 2017 | - | -$94.00 K(-86.1%) | -$4.60 M(-8.2%) |
| July 2017 | - | -$674.00 K(-72.2%) | -$5.01 M(-27.2%) |
| Apr 2017 | -$6.88 M(-34.1%) | -$2.42 M(+72.0%) | -$6.88 M(-2.1%) |
| Jan 2017 | - | -$1.41 M(+179.6%) | -$7.03 M(-12.5%) |
| Oct 2016 | - | -$504.00 K(-80.2%) | -$8.04 M(-20.3%) |
| July 2016 | - | -$2.55 M(-1.1%) | -$10.08 M(-3.5%) |
| Apr 2016 | -$10.45 M(-20.5%) | -$2.57 M(+6.7%) | -$10.45 M(-9.5%) |
| Jan 2016 | - | -$2.41 M(-5.3%) | -$11.55 M(-3.4%) |
| Oct 2015 | - | -$2.55 M(-12.5%) | -$11.95 M(-4.2%) |
| July 2015 | - | -$2.91 M(-20.8%) | -$12.48 M(-4.8%) |
| Apr 2015 | -$13.14 M(+77.4%) | -$3.68 M(+30.6%) | -$13.12 M(+12.0%) |
| Jan 2015 | - | -$2.82 M(-8.5%) | -$11.71 M(+23.7%) |
| Oct 2014 | - | -$3.08 M(-13.2%) | -$9.47 M(+8.7%) |
| July 2014 | - | -$3.55 M(+56.2%) | -$8.71 M(+17.8%) |
| Apr 2014 | -$7.41 M(+17.0%) | -$2.27 M(+295.8%) | -$7.40 M(+3.2%) |
| Jan 2014 | - | -$574.00 K(-75.2%) | -$7.17 M(-5.5%) |
| Oct 2013 | - | -$2.32 M(+3.9%) | -$7.59 M(+4.8%) |
| July 2013 | - | -$2.23 M(+9.1%) | -$7.24 M(+14.4%) |
| Apr 2013 | -$6.33 M(-26.9%) | -$2.05 M(+106.7%) | -$6.33 M(-7.4%) |
| Jan 2013 | - | -$990.00 K(-49.8%) | -$6.84 M(-9.6%) |
| Oct 2012 | - | -$1.97 M(+49.2%) | -$7.57 M(-4.7%) |
| July 2012 | - | -$1.32 M(-48.1%) | -$7.94 M(-8.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2012 | -$8.66 M(+127.8%) | -$2.55 M(+48.3%) | -$8.65 M(-2.2%) |
| Jan 2012 | - | -$1.72 M(-26.8%) | -$8.85 M(+17.3%) |
| Oct 2011 | - | -$2.35 M(+15.3%) | -$7.54 M(+43.7%) |
| July 2011 | - | -$2.04 M(-25.7%) | -$5.25 M(+38.0%) |
| Apr 2011 | -$3.80 M(+30.1%) | -$2.74 M(+560.7%) | -$3.80 M(+135.9%) |
| Jan 2011 | - | -$415.00 K(+668.5%) | -$1.61 M(-18.6%) |
| Oct 2010 | - | -$54.00 K(-90.9%) | -$1.98 M(-21.1%) |
| July 2010 | - | -$591.00 K(+7.1%) | -$2.51 M(-14.1%) |
| Apr 2010 | -$2.92 M(+30.4%) | -$552.00 K(-29.6%) | -$2.92 M(-22.2%) |
| Jan 2010 | - | -$784.00 K(+34.2%) | -$3.76 M(+6.2%) |
| Oct 2009 | - | -$584.00 K(-41.8%) | -$3.54 M(+11.1%) |
| July 2009 | - | -$1.00 M(-27.7%) | -$3.18 M(+37.7%) |
| Apr 2009 | -$2.24 M(+445.5%) | -$1.39 M(+146.4%) | -$2.31 M(+27.7%) |
| Jan 2009 | - | -$563.00 K(+143.1%) | -$1.81 M(+184.4%) |
| Oct 2008 | - | -$231.60 K(+76.8%) | -$636.60 K(+15.6%) |
| July 2008 | - | -$131.00 K(-85.2%) | -$550.60 K(+34.0%) |
| Apr 2008 | -$411.00 K(+141.6%) | -$885.00 K(-244.8%) | -$411.00 K(-208.7%) |
| Jan 2008 | - | $611.00 K(-519.6%) | $378.00 K(-239.9%) |
| Oct 2007 | - | -$145.60 K(-1793.0%) | -$270.20 K(+87.4%) |
| July 2007 | - | $8600.00(-109.0%) | -$144.20 K(-15.2%) |
| Apr 2007 | -$170.10 K(-44.0%) | -$96.00 K(+158.1%) | -$170.10 K(+140.3%) |
| Jan 2007 | - | -$37.20 K(+89.8%) | -$70.80 K(-36.4%) |
| Oct 2006 | - | -$19.60 K(+13.3%) | -$111.30 K(-17.4%) |
| July 2006 | - | -$17.30 K(-624.2%) | -$134.80 K(-61.9%) |
| Apr 2006 | -$303.70 K(+23.2%) | $3300.00(-104.2%) | -$353.40 K(+0.3%) |
| Jan 2006 | - | -$77.70 K(+80.3%) | -$352.40 K(0.0%) |
| Oct 2005 | - | -$43.10 K(-81.7%) | -$352.40 K(-14.7%) |
| July 2005 | - | -$235.90 K(-5586.0%) | -$413.20 K(+67.6%) |
| Apr 2005 | -$246.50 K(+128.9%) | $4300.00(-105.5%) | -$246.60 K(+40.6%) |
| Jan 2005 | - | -$77.70 K(-25.2%) | -$175.40 K(+15.6%) |
| Oct 2004 | - | -$103.90 K(+49.9%) | -$151.70 K(+88.7%) |
| July 2004 | - | -$69.30 K(-191.8%) | -$80.40 K(+37.7%) |
| Apr 2004 | -$107.70 K(-26.2%) | $75.50 K(-239.8%) | -$58.40 K(-70.5%) |
| Jan 2004 | - | -$54.00 K(+65.6%) | -$198.20 K(+5.8%) |
| Oct 2003 | - | -$32.60 K(-31.1%) | -$187.30 K(+59.0%) |
| July 2003 | - | -$47.30 K(-26.4%) | -$117.80 K(-19.3%) |
| Apr 2003 | -$146.00 K(-0.9%) | -$64.30 K(+49.2%) | -$146.00 K(-9.3%) |
| Jan 2003 | - | -$43.10 K(-216.8%) | -$161.00 K(+3.9%) |
| Oct 2002 | - | $36.90 K(-148.9%) | -$155.00 K(-17.9%) |
| July 2002 | - | -$75.50 K(-4.8%) | -$188.90 K(+28.2%) |
| Apr 2002 | -$147.30 K(-78.2%) | -$79.30 K(+113.7%) | -$147.30 K(-50.7%) |
| Jan 2002 | - | -$37.10 K(-1336.7%) | -$298.70 K(-44.6%) |
| Oct 2001 | - | $3000.00(-108.8%) | -$539.20 K(-23.2%) |
| July 2001 | - | -$33.90 K(-85.3%) | -$701.90 K(+3.7%) |
| Apr 2001 | -$676.90 K(-1414.4%) | -$230.70 K(-16.9%) | -$676.80 K(+51.7%) |
| Jan 2001 | - | -$277.60 K(+73.8%) | -$446.10 K(+164.7%) |
| Oct 2000 | - | -$159.70 K(+1714.8%) | -$168.50 K(+1814.8%) |
| July 2000 | - | -$8800.00 | -$8800.00 |
| Apr 2000 | $51.50 K | - | - |
FAQ
- What is Champions Oncology annual net profit?
- What is the all time high annual net income for Champions Oncology?
- What is Champions Oncology annual net income year-on-year change?
- What is Champions Oncology quarterly net profit?
- What is the all time high quarterly net income for Champions Oncology?
- What is Champions Oncology quarterly net income year-on-year change?
- What is Champions Oncology TTM net profit?
- What is the all time high TTM net income for Champions Oncology?
- What is Champions Oncology TTM net income year-on-year change?
What is Champions Oncology annual net profit?
The current annual net income of CSBR is -$7.28 M
What is the all time high annual net income for Champions Oncology?
Champions Oncology all-time high annual net profit is $548.00 K
What is Champions Oncology annual net income year-on-year change?
Over the past year, CSBR annual net profit has changed by -$1.94 M (-36.38%)
What is Champions Oncology quarterly net profit?
The current quarterly net income of CSBR is $1.31 M
What is the all time high quarterly net income for Champions Oncology?
Champions Oncology all-time high quarterly net profit is $1.31 M
What is Champions Oncology quarterly net income year-on-year change?
Over the past year, CSBR quarterly net profit has changed by +$3.38 M (+163.40%)
What is Champions Oncology TTM net profit?
The current TTM net income of CSBR is -$3.40 M
What is the all time high TTM net income for Champions Oncology?
Champions Oncology all-time high TTM net profit is $548.00 K
What is Champions Oncology TTM net income year-on-year change?
Over the past year, CSBR TTM net profit has changed by +$6.24 M (+64.75%)